Validation of the Functional Assessment of Cancer Therapy-Leukemia instrument in patients with acute myeloid leukemia who are not candidates for intensive therapy

首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Validation of the Functional Assessment of Cancer Therapy-Leukemia instrument in patients with acute myeloid leukemia who are not candidates for intensive therapy

【24h】

Validation of the Functional Assessment of Cancer Therapy-Leukemia instrument in patients with acute myeloid leukemia who are not candidates for intensive therapy

机译：患有急性髓白血病患者癌症治疗 - 白血病仪器功能评估的验证

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background The objective of this study was to validate the Functional Assessment of Cancer Therapy-Leukemia (FACT-Leu) in patients with acute myeloid leukemia (AML) who are not candidates for intensive therapy.

机译：背景技术本研究的目的是验证癌症治疗 - 白血病（Fact-Leu）的功能评估，急性髓性白血病（AML）不是密集治疗的候选者。

著录项

来源
《Cancer: A Journal of the American Cancer Society》 |2020年第15期|共10页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
acute myeloid leukemia; Functional Assessment of Cancer Therapy-Leukemia (FACT-Leu); health-related quality of life; leukemia;

机译：急性髓性白血病;癌症治疗 - 白血病的功能评估（事实-euu）;与健康有关的生活质量;白血病;

相似文献

外文文献
中文文献
专利

1. Validation of the Functional Assessment of Cancer Therapy-Leukemia instrument in patients with acute myeloid leukemia who are not candidates for intensive therapy [J] . Cancer: A Journal of the American Cancer Society . 2020,第15期

机译：患有急性髓白血病患者癌症治疗 - 白血病仪器功能评估的验证
2. Selection of Elderly Acute Myeloid Leukemia Patients for Intensive Chemotherapy: Effectiveness of Intensive Chemotherapy and Subgroup Analysis [J] . Kim Dae Sik, Kang Ka Won, Yu Eun Sang, Acta Haematologica . 2015,第3期

机译：老年急性粒细胞白血病患者进行强化学疗法的选择：强化学疗法的有效性和亚组分析
3. Biomarkers of Overall Survival and Response to Glasdegib and Intensive or Non-Intensive Chemotherapy in Patients with Acute Myeloid Leukemia [J] . Cortes Jorge E., Merchant Akil, Jamieson Catriona, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：对急性髓性白血病患者的整体存活和对Glasdegib和密集或非密集化疗的患者的生物标志物
4. Optimal control of a coupled model for healthy and cancerous cells dynamics in Acute Myeloid Leukemia - a therapy approach [C] . Zenati Abdelhafid, Messaoud Chakir, Tadjine Mohamed International Conference on Systems and Control . 2017

机译：急性髓性白血病中健康和癌细胞动态耦合模型的最优控制-一种治疗方法
5. Loss of Egr1 plays a role in murine leukemogenesis and may play a role in the development of acute myeloid leukemia and therapy-related acute myeloid leukemia. [D] . Joslin, John M. 2006

机译：Egr1的丢失在小鼠白血病的发生中起作用，并且可能在急性髓细胞性白血病和与治疗有关的急性髓细胞性白血病的发展中起作用。
6. Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukemia groups (AML-19) [O] . Sergio Amadori, Stefan Suciu, Dominik Selleslag, -1

机译：两次低剂量Gemtuzumab ozogamicin的随机试验作为新诊断的急性髓细胞白血病对老年患者的诱导单一的疗法而不是考虑到密集化疗的候选人。 EITTC和Gimema白血病组的II期研究（AML-19）
7. A quality‐adjusted survival time without symptoms or toxicities analysis of glasdegib plus low‐dose cytarabine versus low‐dose cytarabine as initial therapy for acute myeloid leukemia in patients who are not considered candidates for intensive chemotherapy [O] . Caitlyn T. Solem, Timothy J. Bell, Youngmin Kwon, 2020

机译：没有症状或毒性分析的质量调整的存活时间，没有症状和毒性的患者对低剂量的细胞甘露肠道，作为急性髓鞘中的初始治疗，该患者不被认为是密集化疗的候选者
8. Chemotherapy in a Transplantable Myeloid Leukemia in Brown Norway Rats: Studies on BNML as a Model for Human Acute Myeloid Leukemia [R] . Golly, L. P. 1980

机译：Brown Norway大鼠可移植骨髓性白血病的化疗：BNmL作为人类急性髓性白血病模型的研究

Validation of the Functional Assessment of Cancer Therapy-Leukemia instrument in patients with acute myeloid leukemia who are not candidates for intensive therapy

摘要

著录项

相似文献

相关主题

期刊订阅